Q3 FY15 10-Q
Index

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 for the quarterly period ended March 31, 2015
 
OR
 
o    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 Commission File Number 0-3295
 
KOSS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
 
DELAWARE
 
39-1168275
(State or other jurisdiction of
 
(I.R.S. Employer Identification No.)
incorporation or organization)
 
 
 
4129 North Port Washington Avenue, Milwaukee, Wisconsin
 
53212
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (414) 964-5000
 
Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ  No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes þ  No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. 
Large accelerated filer o
 
Accelerated filer o
 
 
 
Non-accelerated filer o
 
Smaller reporting company þ
(Do not check if a smaller reporting company)
 
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.).  Yes o No þ
 
At May 4, 2015, there were 7,382,706 shares outstanding of the registrant’s common stock. 


Index


KOSS CORPORATION
FORM 10-Q
March 31, 2015

INDEX
 
 
 
 
Page
 
 
 
 

 

 
 
 
 

 
1

 
 
 
 

 
 

 
 
 
 
 
 

 
 
 
 
 
 

 
 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 

 
 
 
 
 



2

Index

PART I
FINANCIAL INFORMATION

Item 1.
   Financial Statements
 
KOSS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
 
 
2015
 
2014
 
2015
 
2014
Net sales
 
$
6,001,556

 
$
4,300,373

 
$
18,511,192

 
$
17,648,927

Cost of goods sold
 
3,886,443

 
3,206,738

 
12,143,055

 
12,145,820

Impairment of capitalized software, inventory and related items
 

 

 

 
4,535,747

Gross profit
 
2,115,113

 
1,093,635

 
6,368,137

 
967,360

 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
 
1,998,231

 
2,354,337

 
6,006,970

 
8,100,477

Unauthorized transaction related costs and (recoveries), net
 
1,078

 
(231,162
)
 
78,570

 
(827,707
)
Total operating expenses
 
1,999,309

 
2,123,175

 
6,085,540

 
7,272,770

 
 
 
 
 
 
 
 
 
Income (loss) from operations
 
115,804

 
(1,029,540
)
 
282,597

 
(6,305,410
)
 
 
 
 
 
 
 
 
 
Other expense (income):
 
 
 
 
 
 
 
 
Interest expense (income)
 

 
(65,536
)
 
12,813

 
(49,737
)
 
 
 
 
 
 
 
 
 
Income (loss) before income tax provision (benefit)
 
115,804

 
(964,004
)
 
269,784

 
(6,255,673
)
 
 
 
 
 
 
 
 
 
Income tax provision (benefit)
 
58,586

 
(938,883
)
 
141,978

 
(2,857,113
)
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
57,218

 
$
(25,121
)
 
$
127,806

 
$
(3,398,560
)
 
 
 
 
 
 
 
 
 
Income (loss) per common share:
 
 
 
 
 
 
 
 
Basic
 
$
0.01

 
$

 
$
0.02

 
$
(0.46
)
Diluted
 
$
0.01

 
$

 
$
0.02

 
$
(0.46
)
 
 
 
 
 
 
 
 
 
Dividends declared per common share
 
$

 
$
0.06

 
$

 
$
0.18

 
The accompanying notes are an integral part of these condensed consolidated financial statements.


3

Index

KOSS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

 
 
(Unaudited)
 
 
 
 
March 31, 2015
 
June 30, 2014
ASSETS
 
 

 
 

Current assets:
 
 

 
 

Cash and cash equivalents
 
$
1,044,578

 
$
1,899,411

Accounts receivable, less allowance for doubtful accounts of $35,865 and
$20,501, respectively
 
2,776,760

 
3,160,887

Inventories
 
6,070,438

 
7,054,932

Prepaid expenses and other current assets
 
531,884

 
148,200

Income taxes receivable
 
277,914

 
1,109,276

Deferred income taxes
 
2,019,218

 
2,576,023

Total current assets
 
12,720,792

 
15,948,729

 
 
 
 
 
Equipment and leasehold improvements, net
 
1,651,768

 
1,840,491

 
 
 
 
 
Other assets:
 
 
 
 
Deferred income taxes
 
1,870,165

 
1,623,329

Cash surrender value of life insurance
 
5,324,142

 
4,977,409

Total other assets
 
7,194,307

 
6,600,738

 
 
 
 
 
Total assets
 
$
21,566,867

 
$
24,389,958

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 

 
 

Current liabilities:
 
 

 
 

Accounts payable
 
$
1,377,609

 
$
2,464,755

Accrued liabilities
 
1,780,750

 
3,853,473

Income taxes payable
 
175,000

 
175,000

Total current liabilities
 
3,333,359

 
6,493,228

 
 
 
 
 
Long-term liabilities:
 
 

 
 

Deferred compensation
 
2,144,255

 
2,320,091

Other liabilities
 
247,079

 
336,772

Total long-term liabilities
 
2,391,334

 
2,656,863

 
 
 
 
 
Total liabilities
 
5,724,693

 
9,150,091

 
 
 
 
 
Stockholders' equity:
 
 

 
 

Common stock, $0.005 par value, authorized 20,000,000 shares; issued and
outstanding 7,382,706 shares
 
36,914

 
36,914

Paid in capital
 
4,470,743

 
3,996,242

Retained earnings
 
11,334,517

 
11,206,711

Total stockholders' equity
 
15,842,174

 
15,239,867

 
 
 
 
 
Total liabilities and stockholders' equity
 
$
21,566,867

 
$
24,389,958

 
 
 
 
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Index

KOSS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
 
 
Nine Months Ended
 
 
March 31
 
 
2015
 
2014
Operating activities:
 
 

 
 

Net income (loss)
 
$
127,806

 
$
(3,398,560
)
Adjustments to reconcile net income (loss) to net cash provided by
(used in) operating activities:
 
 
 
 
Provision for (recoveries of previously written off) doubtful accounts
 
43,278

 
(102,567
)
Loss on disposals of fixed assets
 
14,953

 

Impairment of capitalized software, inventory and related items
 

 
4,535,747

Depreciation of equipment and leasehold improvements
 
437,344

 
569,027

Amortization of product software development expenditures
 

 
364,539

Stock-based compensation expense
 
474,501

 
516,829

Deferred income taxes
 
309,969

 
(2,434,674
)
Change in cash surrender value of life insurance
 
(114,952
)
 
(86,486
)
Deferred compensation
 
(25,836
)
 
(357,923
)
Net changes in operating assets and liabilities (see note 10)
 
(1,626,541
)
 
4,336,319

Cash provided by (used in) operating activities
 
(359,478
)
 
3,942,251

 
 
 
 
 
Investing activities:
 
 

 
 

Life insurance premiums paid
 
(231,781
)
 
(243,299
)
Purchase of equipment and leasehold improvements
 
(263,574
)
 
(480,497
)
Cash used in investing activities
 
(495,355
)
 
(723,796
)
 
 
 
 
 
Financing activities:
 
 

 
 

Dividends paid to stockholders
 

 
(1,328,887
)
Cash used in financing activities
 

 
(1,328,887
)
 
 
 
 
 
Net increase (decrease) in cash and cash equivalents
 
(854,833
)
 
1,889,568

Cash and cash equivalents at beginning of period
 
1,899,411

 
859,636

Cash and cash equivalents at end of period
 
$
1,044,578

 
$
2,749,204

 
The accompanying notes are an integral part of these condensed consolidated financial statements.



5

Index


KOSS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2015
(Unaudited)

1.    CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The condensed consolidated balance sheets of Koss Corporation (the "Company") as of June 30, 2014 have been derived from audited financial statements.  The unaudited condensed consolidated financial statements presented herein are based on interim amounts.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows for all periods presented have been made.  The operating results for the nine months ended March 31, 2015 are not necessarily indicative of the operating results that may be experienced for the full fiscal year ending June 30, 2015.
 
These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.


2.    UNAUTHORIZED TRANSACTION RELATED COSTS AND RECOVERIES
 
In December 2009, the Company learned of significant unauthorized transactions as previously reported.  The Company has ongoing costs and recoveries associated with the unauthorized transactions. For the three and nine months ended March 31, 2015 and 2014, the costs incurred were for legal fees related to claims initiated against third parties (see Note 12). For the three and nine months ended March 31, 2015 and 2014, the costs and recoveries were as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
 
 
2015
 
2014
 
2015
 
2014
Legal fees incurred
 
$
37,500

 
$
86,391

 
$
114,992

 
$
306,375

Proceeds from asset forfeitures
 
(36,422
)
 
(317,553
)
 
(36,422
)
 
(1,134,082
)
Unauthorized transaction related costs and (recoveries), net
 
$
1,078

 
$
(231,162
)
 
$
78,570

 
$
(827,707
)


3.    IMPAIRMENT OF CAPITALIZED SOFTWARE, INVENTORY AND RELATED ITEMS

The Company recorded an impairment charge to the condensed consolidated statements of operations line item titled "Impairment of capitalized software, inventory and related items" in the three months ended December 31, 2013. The impairment charge is detailed in the following table:
 
Nine Months Ended
 
 
March 31, 2014
Product software development expenditures
 
$
2,308,752

Inventories
 
1,759,710

Product design costs
 
263,503

Tooling
 
203,782

Impairment of capitalized software, inventory and related items
 
$
4,535,747


The Company determined that the capitalized software needed to be replaced by a new architecture under development, which began in the three months ended December 31, 2013. As a result, the remaining value was expensed for the three months ended December 31, 2013. The Company continues to believe in the viability of this technology but has temporarily suspended its research and development effort until the base business is restored to more profitable levels.


6

Index

In conjunction with the review of the capitalized software, it was determined that certain inventory items were obsolete or the Company had quantities that are not expected to be used over the product forecast period. These inventory items are included net of expected recoveries. Product design costs and assumed liabilities to wrap up the current architecture design were expensed. Tooling related to products that are no longer expected to be launched was expensed. To the extent the Company incurs future costs for the continued development, software code and product launch of the WiFi-based products, then those costs will be expensed as incurred. Refer to the Company's 10-K dated June 30, 2014 for a detail of additional impairment charges recorded in the three months ended June 30, 2014.


4.    INVENTORIES
 
The components of inventories at March 31, 2015 and June 30, 2014 were as follows:
 
 
March 31, 2015
 
June 30, 2014
Raw materials
 
$
5,329,231

 
$
5,593,159

Finished goods
 
5,268,877

 
6,327,221

 
 
10,598,108

 
11,920,380

Allowance for obsolete inventory
 
(4,527,670
)
 
(4,865,448
)
Total inventories
 
$
6,070,438

 
$
7,054,932



5.    INCOME TAXES
 
The Company files income tax returns in the United States federal jurisdiction and in several state jurisdictions.  The Company’s federal tax returns for tax years beginning July 1, 2011 or later are open.  During the quarter ended December 31, 2014, the Company's federal return for the fiscal year ended June 30, 2013 was under examination. That examination closed during the same quarter with no adjustments to the return. For states in which the Company files state income tax returns, the statute of limitations is generally open for tax years ended June 30, 2011 and forward.

For the nine months ended March 31, 2015, the Company recorded an income tax expense of $141,978, compared to an income tax benefit of $2,857,113 for the nine months ended March 31, 2014. The increase in the Company's tax expense for the nine months ended March 31, 2015 relative to the prior year primarily resulted from pre-tax book income compared to a pre-tax loss after the impairment charge in the prior year period.

The Company’s unrecognized tax benefits, including interest and penalties, were $175,000 as of March 31, 2015 and as of June 30, 2014. All of the Company’s unrecognized tax benefits as of March 31, 2015, if recognized, would impact the effective tax rate.


6.    CREDIT FACILITY
 
On May 12, 2010, the Company entered into a secured credit facility (“Credit Agreement”) with JPMorgan Chase Bank, N.A. (“Lender”).  The Credit Agreement provided for an $8,000,000 revolving secured credit facility with interest rates either ranging from 0.0% to 0.75% over the Lender’s most recently publicly announced prime rate or 2.0% to 3.0% over LIBOR, depending on the Company’s leverage ratio.  The Company pays a fee of 0.3% to 0.45% for unused amounts committed in the credit facility.  On July 24, 2013, the Credit Agreement was amended to extend the expiration to July 31, 2015. On July 23, 2014 the Credit Agreement was amended to reduce the facility to $5,000,000, subject to a borrowing base calculation as defined in the Credit Agreement, and to amend certain financial covenants. In addition to the revolving loans, the Credit Agreement also provides that the Company may, from time to time, request the Lender to issue letters of credit for the benefit of the Company of up to a sublimit of $2,000,000 and subject to certain other limitations.  The loans may be used only for general corporate purposes of the Company.
 
The Credit Agreement contains certain affirmative, negative and financial covenants customary for financings of this type.  The negative covenants include restrictions on other indebtedness, liens, fundamental changes, certain investments, asset sales, sale and leaseback transactions and transactions with affiliates, among other restrictions.  The financial covenants include minimum EBITDA and minimum tangible net worth requirements.  The Company and the Lender also entered into the Pledge and

7

Index

Security Agreement dated May 12, 2010 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement.


7.    INTEREST EXPENSE

The Company incurs interest expense primarily related to its secured credit facility (see Note 6) and to its liabilities for its tax positions related to the unauthorized transactions. As the tax returns have been settled and statute of limitations have expired, the accrued interest expense on certain items has been reversed. Interest expense detail was as follows for the three and nine months ended March 31, 2015 and 2014, respectively:
 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
 
 
2015
 
2014
 
2015
 
2014
Interest expense (benefit) on secured credit facility
 
$

 
$

 
$
12,813

 
$
(587
)
Interest expense for tax positions related to unauthorized transactions
 

 

 

 
16,386

Interest reversals for tax positions related to unauthorized transactions
 

 
(65,536
)
 

 
(65,536
)
Interest expense (income)
 
$

 
$
(65,536
)
 
$
12,813

 
$
(49,737
)


8.    INCOME (LOSS) PER COMMON AND COMMON STOCK EQUIVALENT SHARE
 
Basic income (loss) per share is computed based on the weighted-average number of common shares outstanding.  The weighted-average number of common shares outstanding was 7,382,706 for the quarters ended March 31, 2015 and 2014.  When dilutive, stock options are included in income (loss) per share as share equivalents using the treasury stock method.  For the periods ended March 31, 2015 and 2014, there were no common stock equivalents related to stock option grants that were included in the computation of the weighted-average number of shares outstanding for diluted income (loss) per share.  Shares issuable upon the exercise of outstanding options of 2,280,000 and 2,186,000 were excluded from the diluted weighted-average common shares outstanding for the periods ended March 31, 2015 and 2014, respectively, as they would be anti-dilutive.


9.    STOCK OPTIONS
 
The Company recognizes stock-based compensation expense for options granted under both the 1990 Flexible Incentive Plan and the 2012 Omnibus Incentive Plan. The stock-based compensation relates to stock options granted to employees, non-employee directors and non-employee consultants. In the nine months ended March 31, 2015, options to purchase 445,000 shares were granted under the 2012 Omnibus Incentive Plan at a weighted average exercise price of $3.19. In the nine months ended March 31, 2014, options to purchase 445,000 shares were granted under the 2012 Omnibus Incentive Plan at a weighted average exercise price of $5.64. Stock-based compensation expense during the three and nine months ended March 31, 2015 was $156,010 and $474,501, respectively. Stock-based compensation expense during the three and nine months ended March 31, 2014 was $172,477 and $516,829, respectively.



8

Index

10.    ADDITIONAL CASH FLOW INFORMATION
 
The net changes in cash as a result of changes in operating assets and liabilities consist of the following:
 
 
Nine Months Ended
 
 
March 31
 
 
2015
 
2014
Accounts receivable
 
$
340,849

 
$
9,938,339

Inventories
 
984,494

 
(926,239
)
Income taxes receivable
 
831,362

 

Prepaid expenses and other current assets
 
(383,684
)
 
125,794

Income taxes payable
 

 
(2,447,939
)
Accounts payable
 
(1,087,146
)
 
(904,445
)
Accrued liabilities
 
(2,222,723
)
 
(1,158,181
)
Other liabilities
 
(89,693
)
 
(291,010
)
Net change
 
$
(1,626,541
)
 
$
4,336,319

 
 
 
 
 
Net cash (refunded) paid during the period for:
 
 

 
 

Income taxes
 
$
(988,785
)
 
$
2,029,000

Interest
 
$
12,813

 
$
2,185



11.    STOCKHOLDERS' EQUITY
 
The following table summarizes the changes in stockholders’ equity for the nine months ended March 31, 2015 and 2014:
 
 
Nine Months Ended
 
 
March 31
 
 
2015
 
2014
Net income (loss)
 
$
127,806

 
$
(3,398,560
)
Dividends declared
 

 
(1,328,887
)
Stock-based compensation expense
 
474,501

 
516,829

Income tax benefit from dividends paid to employee stock ownership plan
 

 
12,432

Increase (decrease) in stockholders' equity
 
$
602,307

 
$
(4,198,186
)



9

Index

12.    LEGAL MATTERS
 
As of March 31, 2015, the Company is party to the matters described below:

On February 18, 2010, the Company filed an action against American Express Company, American Express Travel Related Services Company, Inc., AMEX Card Services Company, Decision Science, and Pamela S. Hopkins in Superior Court of Maricopa County, Arizona, case no. CV2010-006631. The claims alleged include aiding and abetting breach of fiduciary duty, aiding and abetting fraud, and conversion relating to the unauthorized transactions.  The case is proceeding in the Superior Court with respect to those claims. 

On December 17, 2010, the Company filed an action against Park Bank in Circuit Court of Milwaukee County, Wisconsin alleging claims of negligence and breach of fiduciary duty relating to the unauthorized transactions. The Company voluntarily dismissed the negligence claim and the case is proceeding in the Circuit Court. 

On March 6, 2014, the Company filed an action against Red Fusion Studios, Inc. ("Red Fusion") in Circuit Court of Milwaukee County, Wisconsin, Case No. 14CV001885, seeking the return of the Company's property and damages following the termination of the agreement that the Company had with Red Fusion for the development of the Company's STRIVA Technology. Red Fusion filed counterclaims relating to fees that Red Fusion alleges it is owed as a result of the termination. The Parties reached a confidential settlement that dismissed all claims involved in this action.

On January 26, 2015, Sapphire Dolphin, LLC filed a patent infringement case against the Company in the United States District Court for the District of Delaware, Case No. 1-15-cv-00085. The Company is planning to file an Answer and defend the case.
 
The ultimate resolution of these matters is not determinable unless otherwise noted.

We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving these claims against us, individually or in aggregate, will not have a material adverse impact on our consolidated financial statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future.




10

Index


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
This Form 10-Q contains forward-looking statements within the meaning of that term in the Private Securities Litigation Reform Act of 1995 (the “Act”) (Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).  Additional written or oral forward-looking statements may be made by the Company from time to time in filings with the Securities Exchange Commission, press releases, or otherwise.  Statements contained in this Form 10-Q that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Act.  Forward-looking statements may include, but are not limited to, projections of revenue, income or loss and capital expenditures, statements regarding future operations, anticipated financing needs, compliance with financial covenants in loan agreements, plans for acquisitions or sales of assets or businesses, plans relating to products or services of the Company, assessments of materiality, predictions of future events, the effects of pending and possible litigation and assumptions relating to the foregoing.  In addition, when used in this Form 10-Q, the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “may,” “will,” “should,” “forecasts,” “anticipates,” “predicts,” “potential,” “continue” and variations thereof and similar expressions are intended to identify forward-looking statements.
 
Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified based on current expectations.  Consequently, future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements contained in this Form 10-Q, or in other Company filings, press releases, or otherwise.  In addition to the factors discussed in this Form 10-Q, other factors that could contribute to or cause such differences include, but are not limited to, developments in any one or more of the following areas: future fluctuations in economic conditions, the receptivity of consumers to new consumer electronics technologies, the rate and consumer acceptance of new product introductions, competition, pricing, the number and nature of customers and their product orders, production by third party vendors, foreign manufacturing, sourcing, and sales (including foreign government regulation, trade and importation concerns), borrowing costs, changes in tax rates, pending or threatened litigation and investigations, and other risk factors which may be detailed from time to time in the Company’s Securities and Exchange Commission filings.
 
Readers are cautioned not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date hereof.  The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect new information.



11

Index

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Overview
 
The Company markets a complete line of high-fidelity headphones, wireless Bluetooth® speakers, computer headsets, telecommunications headsets, active noise canceling headphones, wireless headphones and compact disc recordings of American Symphony Orchestras on the Koss Classics label. The Company operates as one business segment.

In December 2009, the Company learned of significant unauthorized transactions, details of which have been disclosed in depth in the Company's previous periodic reports filed with the SEC. References to unauthorized transactions below should be read in conjunction with those reports.

Results of Operations Summary

Net sales in the quarter ended March 31, 2015 increased 39.6%, to $6,001,556, compared to the same quarter last year. Increased sales in export markets and certain domestic distributors and retail outlets were the primary causes of this improvement. For the nine months ended March 31, 2015, net sales were up 4.9% compared to the same period last year, with higher sales in certain domestic distributors.
Gross profit as a percent of sales increased to 35.2% and 34.4% for the three and nine months ended March 31, 2015, respectively, compared to 25.4% and 5.5% for the three and nine months ended March 31, 2014, respectively. This increase is primarily due to the impairment charge recorded in the quarter ended December 31, 2013. Gross profit also improved as a result of closing the operations in Mexico during the quarter ended September 30, 2014.
Selling, general and administrative spending was lower primarily due to reduced software development expenditures, reduced expense for legal fees and other outside services, reduced 401(k) match, reduced endorsement fees and reduced trade show expenses. In addition, the sales office in Switzerland was closed in October 2013.

Financial Results

The following table presents selected financial data for the three and nine months ended March 31, 2015 and 2014.

 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
Financial Performance Summary
 
2015
 
2014
 
2015
 
2014
Net sales
 
$
6,001,556

 
$
4,300,373

 
$
18,511,192

 
$
17,648,927

Net sales increase (decrease) %
 
39.6
%
 
(48.2
)%
 
4.9
%
 
(31.7
)%
Impairment of capitalized software, inventory and related items
 
$

 
$

 
$

 
$
4,535,747

Gross profit
 
$
2,115,113

 
$
1,093,635

 
$
6,368,137

 
$
967,360

Gross profit as % of net sales
 
35.2
%
 
25.4
 %
 
34.4
%
 
5.5
 %
Gross profit as % of net sales before impairment
 
35.2
%
 
25.4
 %
 
34.4
%
 
31.2
 %
Selling, general and administrative expenses
 
$
1,998,231

 
$
2,354,337

 
$
6,006,970

 
$
8,100,477

Selling, general and administrative expenses as a % of sales
 
33.3
%
 
54.7
 %
 
32.5
%
 
45.9
 %
Unauthorized transaction related costs
 
$
37,500

 
$
86,391

 
$
114,992

 
$
306,375

Unauthorized transaction related recoveries
 
$
(36,422
)
 
$
(317,553
)
 
$
(36,422
)
 
$
(1,134,082
)
Unauthorized transaction related costs and (recoveries), net
 
$
1,078

 
$
(231,162
)
 
$
78,570

 
$
(827,707
)
Income (loss) from operations
 
$
115,804

 
$
(1,029,540
)
 
$
282,597

 
$
(6,305,410
)
Income (loss) from operations as % of net sales
 
1.9
%
 
(23.9
)%
 
1.5
%
 
(35.7
)%
Interest expense (income)
 
$

 
$
(65,536
)
 
$
12,813

 
$
(49,737
)
Income tax provision (benefit)
 
$
58,586

 
$
(938,883
)
 
$
141,978

 
$
(2,857,113
)
Income tax provision (benefit) as % of income before income tax provision (benefit)
 
50.6
%
 
97.4
 %
 
52.6
%
 
45.7
 %



12

Index

2015 Results Compared with 2014  
(comments refer to both the three and nine month periods unless otherwise stated)

Net sales increased in the three months ended March 31, 2015 by $1,701,183 or 39.6%, as sales in certain export markets and sales to certain domestic distributors and retail outlets improved. For the nine months ended March 31, 2015, net sales increased by $862,265 or 4.9%, due to increased sales to certain domestic distributors.

The fiscal year started with export sales well behind last year with weakness in most of the major export markets. This trend changed in the quarter ended December 31, 2014 and continued to improve in the quarter ended March 31, 2015 as improved sales in Scandinavia and continued strong sales in Russia and Malaysia offset the continued weakness in markets such as Ukraine, Czech Republic and Japan. The distributor in Scandinavia appears to have worked through their excess inventory and had strong sales in the current and prior quarters. Management believes many other customers in Europe are dealing with the impact of weak economies, which affect sell-through and their ability to properly balance inventories. The distributor in Ukraine continues to be affected by political unrest in that region. In addition, sales to our distributor in the Czech Republic were down considerably as they adjust inventory levels following two very strong years ended June 30, 2014.

In the domestic market, net sales were up considerably over last year with U.S. distributors showing strong increases. The domestic sales increased by approximately 66% for the quarter ended March 31, 2015, bringing the nine month increase to approximately 13%. The strong sales through distributors, e-commerce, OEM, certain mass retailers and grocery chains helped to offset the decreased sales in one mass retailer and the loss of sales through electronics and drug store chains. Last year's promotional load-in of products to a domestic drug store customer resulted in net sales for the nine months ended March 31, 2014 of approximately $426,000. In the three months ended March 31, 2014, a provision for expected product returns was increased by approximately $973,000 resulting in sales return accruals exceeding sales to that drug store customer in that quarter. The improvements in certain channels helped to offset the load-in shipments to certain customers last year that were not repeated in the current year.
 
Gross profit as a percent of sales was higher than last year primarily as a result of the impairment charge recorded in the three months ended December 31, 2013.

Gross profit before the impairment charge was 35.2% and 34.4% for the three and nine months ended March 31, 2015, respectively. This is an improvement from the 25.4% and 31.2% recorded in the three and nine months ended March 31, 2014, respectively. The higher gross profit margins are the result of decreased overhead costs and no longer recording amortization expense for the software written off as part of the impairment charge recorded in the quarter ended December 31, 2013. The expenses are lower due to closing the Mexico operations, which were just beginning to come on line last year, as well as reduced overhead spending in Milwaukee. These helped offset lower contribution margins driven by competitive pricing and the impact of some closeout sales at very low margins.

Selling, general and administrative expenses were lower than the same period last year. The Company reduced spending on the development of the STRIVA product line resulting in a decrease of approximately $28,000 and $809,000 for the three and nine months ended March 31, 2015, respectively. Legal fees and outside service fees declined by approximately $127,000 and $619,000 for the three and nine months ended March 31, 2015, respectively, due to changes in the scope of work as well as price discounts. The 401(k) match was lower by approximately $71,000 and $251,000 for the three and nine months ended March 31, 2015, respectively, resulting from a reduced match percentage this year. Endorsement fees were lower than last year by approximately $6,000 and $178,000 for the three and nine months ended March 31, 2015, respectively. The Company did not participate in the Consumer Electronics Show (CES) in fiscal 2015 which reduced expenses by approximately $167,000 in the three and nine months ended March 31, 2015. The sales office in Switzerland was closed following the quarter ended September 30, 2013 and reduced expenses by approximately $118,000 for the nine months ended March 31, 2015. Sales for Europe are now supported from an office in Ireland. Sales for Asia and Latin America are supported by U.S.-based personnel.

The Company believes that most of the proceeds from asset forfeitures have been received as of March 31, 2015. Final proceeds are expected to be received in the fiscal year ended June 30, 2015.
 
The increase in income from operations for the quarter ended March 31, 2015 was primarily due to the increase in net sales and the cost reductions detailed above.
 
The effective income tax rate for the nine months ended March 31, 2015 was 52.6% which is comprised of the U.S. federal statutory rate of 34%, the effect of state income taxes, the impact of certain permanent differences in relation to low pre-tax income and the impact of certain discrete items recorded in the nine months ended March 31, 2015. It is anticipated that the effective income tax rate will be approximately 50% in the year ended June 30, 2015.

13

Index


Non-GAAP Financial Measures

The Company's management uses the non-GAAP measurement of earnings before interest, taxes, depreciation and amortization ("EBITDA") to track performance from operations. EBIDTA as calculated below is one of the amended covenants in the Company's credit agreement with JPMorgan Chase Bank, N.A. This measurement excludes unusual and non-recurring expenses and recoveries related to the unauthorized transactions and the charge to expense for the impairment of capitalized software, inventory and related items. The following table reconciles net income (loss) for the periods presented (GAAP financial measure) to non-GAAP EBITDA from operations.

 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
 
 
2015
 
2014
 
2015
 
2014
Net income (loss)
 
$
57,218

 
$
(25,121
)
 
$
127,806

 
$
(3,398,560
)
Interest expense (income)
 

 
(65,536
)
 
12,813

 
(49,737
)
Income tax provision (benefit)
 
58,586

 
(938,883
)
 
141,978

 
(2,857,113
)
Unauthorized transaction related costs and (recoveries), net
 
1,078

 
(231,162
)
 
78,570

 
(827,707
)
Depreciation of equipment and leasehold improvements
 
108,544

 
146,849

 
437,344

 
569,027

Amortization of product software development expenditures
 

 

 

 
364,539

Impairment of capitalized software, inventory and related items
 

 

 

 
4,535,747

Stock-based compensation expense
 
156,010

 
172,477

 
474,501

 
516,829

EBITDA from operations
 
$
381,436

 
$
(941,376
)
 
$
1,273,012

 
$
(1,146,975
)

Non-GAAP EBITDA from operations increased to 6.4% of net sales for the three months ended March 31, 2015 compared to (21.9)% of net sales in the three months ended March 31, 2014. For the nine months ended March 31, 2015 and 2014, non-GAAP EBITDA from operations was 6.9% and (6.5)% of net sales, respectively. This increase reflects the cost reductions achieved through suspending operations in Mexico, suspending development of the STRIVA product line and the other reductions in selling, general and administrative spending described above.

Liquidity and Capital Resources
 
Cash Flows

The following table summarizes our cash flows from operating, investing and financing activities for the nine months ended March 31, 2015 and 2014:

 
 
Nine Months Ended
 
 
March 31
Total cash provided by (used in):
 
2015
 
2014
Operating activities
 
$
(359,478
)
 
$
3,942,251

Investing activities
 
(495,355
)
 
(723,796
)
Financing activities
 

 
(1,328,887
)
Net increase (decrease) in cash and cash equivalents
 
$
(854,833
)
 
$
1,889,568




14

Index

Operating Activities
 
In the nine months ended March 31, 2015, the Company paid approximately $1.5 million for returned product received in the year ended June 30, 2014, as the customer did not buy sufficient new products to offset these returns. In addition, there were payments to vendors for inventory related to new products and fall customer promotions, issuance of volume rebates for export customers and payments related to the suspension of operations in Mexico. These items were partially offset by receiving approximately $1.0 million of federal tax refunds. During the nine months ended March 31, 2014, cash provided by operations was primarily due to receiving the proceeds of the settlement of the lawsuit against the Company's former auditors. Pursuant to the settlement, in July 2013, the Company received gross proceeds of $8,500,000, or $6,380,000 net of associated legal fees. During the quarter ended September 30, 2013, the Company paid approximately $2,000,000 for federal taxes.

Inventories decreased by approximately $984,000 in the nine months ended March 31, 2015. This decrease was caused by the improvement in sales, balancing key stock levels to activity and closeout sales of slow moving items.

Investing Activities
 
Cash used in investing activities was lower for the nine months ended March 31, 2015 as the Company had lower capital expenditures for tooling related to new products. The Company anticipates it will incur total expenditures of approximately $350,000 to $400,000 for tooling, leasehold improvements and capital expenditures during the fiscal year ending June 30, 2015.  The Company expects to generate sufficient cash flow through operations or through the use of its credit facility to fund these expenditures.
 
Financing Activities
 
The payment of quarterly dividends resulted in a net use of cash in financing activities for the nine months ended March 31, 2014. The Company has suspended payments of quarterly dividends until operations and earnings improve. The Company will determine whether to declare and the amount of any future dividends based upon its assessment of the Company’s financial condition and liquidity, improvement in sales as a whole and in particular in the export markets, an increased generation of cash from operations and the Company’s earnings. As of March 31, 2015, the Company had no outstanding borrowings on its bank line of credit facility.

There were no purchases of common stock in 2015 or 2014 under the stock repurchase program.  No stock options were exercised in 2015 or 2014.
 
Liquidity
 
In addition to capital expenditures for tooling, the Company has interest payments on its borrowings when it uses its line of credit facility, and has paid regular quarterly dividends until no dividend was declared for the quarter ended June 30, 2014. The Company will not declare a dividend for the quarter ended March 31, 2015. The Company believes that cash generated from operations, together with cash reserves and borrowings available under its credit facility, provide it with adequate liquidity to meet operating requirements, debt service requirements and planned capital expenditures for the next twelve months and thereafter for the foreseeable future. Whether there is adequate liquidity to resume paying quarterly dividends, and if so, the amount per share of such dividends, will be dependent on certain factors, including the Company’s financial condition and liquidity, an improvement in sales as a whole and in particular in the export markets, an increased generation of cash from operations and the Company’s overall earnings. Management believes additional improvements in sales, and controlling the amount of both capital expenditures and operating expenses, are important factors for improving the Company’s liquidity. The Company regularly evaluates new product offerings, inventory levels and capital expenditures to ensure that it is effectively allocating resources in line with current market conditions.


15

Index

Credit Facility
 
On May 12, 2010, the Company entered into a secured credit facility (“Credit Agreement”) with JPMorgan Chase Bank, N.A. (“Lender”).  The Credit Agreement provided for an $8,000,000 revolving secured credit facility and letters of credit for the benefit of the Company of up to a sublimit of $2,000,000.  On July 24, 2013, the Credit Agreement was amended to extend the expiration to July 31, 2015.  On July 23, 2014, the Credit Agreement was amended to lower the revolving credit line to $5,000,000 and to amend certain financial covenants. The Company and the Lender also entered into a Pledge and Security Agreement dated May 12, 2010 under which the Company granted the Lender a security interest in substantially all of the Company’s assets in connection with the Company’s obligations under the Credit Agreement.  The Company is currently in compliance with all covenants related to the Credit Facility. As of March 31, 2015 and June 30, 2014, there were no outstanding borrowings on the facility.

Off-Balance Sheet Arrangements
 
The Company has no off-balance sheet arrangements other than the lease for the facility in Milwaukee, Wisconsin. The Company leases the facility from Koss Holdings, LLC, which is wholly-owned by John C. Koss.  On May 15, 2012, the lease was renewed for a period of five years, ending June 30, 2018, and is being accounted for as an operating lease.  The lease extension maintained the rent at a fixed rate of $380,000 per year.  The Company is responsible for all property maintenance, insurance, taxes and other normal expenses related to ownership.  The facility is in good repair and, in the opinion of management, is suitable and adequate for the Company’s business purposes.


16

Index


Item 3.
Quantitative and Qualitative Disclosures About Market Risk
 
Not applicable. 


Item 4.
Controls and Procedures
 
Disclosure Controls and Procedures
 
Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are designed to ensure that: (1) information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (2)  such information is accumulated and communicated to management, including the chief executive officer and principal financial officer, to allow timely decisions regarding required disclosures.  There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures.  Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.
 
The Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2015.  The Company’s management has concluded that the Company’s disclosure controls and procedures as of March 31, 2015 were effective.

 
Changes in Internal Control Over Financial Reporting
 
There have not been any changes in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.





17

Index


PART II
OTHER INFORMATION
 
Item 1.
 Legal Proceedings
 
As of March 31, 2015, the Company is currently involved in legal matters that are described in Note 12 to the condensed consolidated financial statements, which description is incorporated herein by reference.

Item 1A.
Risk Factors
 
Not applicable.
 
Item 2.
 Unregistered Sales of Equity Securities and Use of Proceeds
 
The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 31, 2015, by the Company.
 
COMPANY REPURCHASES OF EQUITY SECURITIES
 
Period (2015)
 
Total # of
Shares
Purchased
 
Average
Price Paid
per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plan (1)
 
Approximate Dollar Value of Shares Available under Repurchase Plan
January 1 - March 31
 

 
$

 

 
$
2,139,753

 

(1)          In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account.  Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program.  The most recent increase was for an additional $2,000,000 in October 2006, for a maximum of $45,500,000 of which $43,360,247 had been expended through March 31, 2015.
 
Item 3.
Defaults Upon Senior Securities
 
None.
 
Item 4.
Mine Safety Disclosures
 
Not applicable.

Item 5.
Other Information
 
None.
 
Item 6.
Exhibits
 
See Exhibit Index attached hereto.


18

Index


SIGNATURES
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
KOSS CORPORATION
 
 
 
 
 
/s/ Michael J. Koss
 
May 8, 2015
Michael J. Koss
 
Chairman
 
President
 
Chief Executive Officer
 
Chief Operating Officer
 
 
 
 
 
/s/ David D. Smith
 
May 8, 2015
David D. Smith
 
Executive Vice President
 
Chief Financial Officer
 
(Principal Financial and Principal Accounting Officer)
 
Secretary
 


19

Index

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
EXHIBIT INDEX
 
Exhibit No.
Exhibit Description
 
 
31.1
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer *
 
 
31.2
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer *
 
 
32.1
Section 1350 Certification of Chief Executive Officer **
 
 
32.2
Section 1350 Certification of Chief Financial Officer **
 
 
101
The following financial information from Koss Corporation's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended March 31, 2015 and 2014, (ii) Condensed Consolidated Balance Sheets as of March 31, 2015 (Unaudited) and June 30, 2014 (iii) Condensed Consolidated Statements of Cash Flows (Unaudited) for the three and nine months ended March 31, 2015 and 2014 and (iv) the Notes to Condensed Consolidated Financial Statements (Unaudited). *

__________________________
*
Filed herewith
**
Furnished herewith



20
Koss Exhibit 31.1 03.31.2015


Exhibit 31.1
 
Certification of Chief Executive Officer 
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Michael J. Koss, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of Koss Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
 
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.            I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 
 
Dated: May 8, 2015
 
 
 
/s/ Michael J. Koss
 
Michael J. Koss
 
Chief Executive Officer, President and
 
Chief Operating Officer
 


Koss Exhibit 31.2 03.31.2015


Exhibit 31.2
 
Certification of Chief Financial Officer 
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, David D. Smith, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of Koss Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its subsidiary, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
 
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.            I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 
 
Dated: May 8, 2015
 
 
 
/s/ David D. Smith
 
David D. Smith
 
Executive Vice President and
 
Chief Financial Officer
 


Koss Exhibit 32.1 03.31.2015


Exhibit 32.1
 
Certification of Chief Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350
 
I, Michael J. Koss, Chief Executive Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:
 
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ Michael J. Koss
 
Michael J. Koss
 
Chief Executive Officer, President and
 
Chief Operating Officer
 
Dated: May 8, 2015
 
 
Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
 



Koss Exhibit 32.2 03.31.2015


Exhibit 32.2
 
Certification of Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 
18 U.S.C. Section 1350
 
I, David D. Smith, Chief Financial Officer of Koss Corporation (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that to my knowledge:
 
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ David D. Smith
 
David D. Smith
 
Executive Vice President and
 
Chief Financial Officer
 
Dated: May 8, 2015
 
 
Note:  This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed, except to the extent required by the Sarbanes-Oxley Act of 2002, by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.